Suchergebnisse - "Halpin, David M G"

PubPharm (12)

1

Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards : an observational longitudinal study

enthalten in: The Lancet regional health. Europe | 2023

von Halpin, D. | Dickens, A. | Skinner, D. | +22

2

Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline

enthalten in: Respiratory medicine | 2022

von Bourdin, A. | Virchow, J. | Papi, A. | +11

3

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD : The IMPACT Study

enthalten in: Advances in therapy | 2020

von Tabberer, M. | Jones, C. | Kilbride, S. | +12

ErratumIn: Adv Ther. 2022 Mar;39(3):1446. - PMID 35060093

4

Composite endpoints in COPD : clinically important deterioration in the UPLIFT trial

enthalten in: Respiratory research | 2020

von Rabe, K. | Halpin, D. | Han, M. | +5

5

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

enthalten in: Advances in therapy | 2020

von Tabberer, M. | Jones, C. | Kilbride, S. | +12

6

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

enthalten in: Respiratory research | 2020

von Rabe, K. | Halpin, D. | Han, M. | +5

7

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

enthalten in: Advances in therapy | 2020

von Tabberer, M. | Jones, C. | Kilbride, S. | +12

8

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

enthalten in: Respiratory research | 2020

von Rabe, K. | Halpin, D. | Han, M. | +5

9

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

enthalten in: Advances in therapy | 2020

von Tabberer, M. | Jones, C. | Kilbride, S. | +12

10

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year $ UPLIFT^{®} $ Trial

enthalten in: Lung | 2011

von Halpin, D. | Decramer, M. | Celli, B. | +3